Skip to main content



) --

West Pharmaceutical Services



) hit a new 52-week high Thursday as it is currently trading at $46.94, above its previous 52-week high of $46.56 with 29,508 shares traded as of 10 a.m. ET. Average volume has been 152,300 shares over the past 30 days.

West Pharmaceutical Services has a market cap of $1.55 billion and is part of the

health care

sector and

health services

industry. Shares are up 21.3% year to date as of the close of trading on Wednesday.

Scroll to Continue

TheStreet Recommends

West Pharmaceutical Services, Inc. manufactures and sells components and systems for injectable drug delivery and plastic packaging, and delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company has a P/E ratio of 18.9, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates West Pharmaceutical Services as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full

West Pharmaceutical Services Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center